Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Andrew Zolp"'
Publikováno v:
Cells, Vol 11, Iss 5, p 896 (2022)
Polyamines are ubiquitous, amine-rich molecules with diverse processes in biology. Recent work has highlighted that polyamines exert profound roles on the mammalian immune system, particularly inflammation and cancer. The mechanisms by which they con
Externí odkaz:
https://doaj.org/article/89518f9902604b8e933e03c47f28f5c4
Autor:
David Hou, Brandyn Castro, Mark Dapash, Andrew Zolp, Joshua Katz, Víctor Arrieta, Jana Biermann, Johannes Melms, Jan Kueckelhaus, Jasim Benotmane, Mark Youngblood, Aida Rashidi, Leah Billingham, Crismita Dmello, Gustavo Vazquez-Cervantes, Aurora Lopez-Rosas, Yu Han, Ronit Patel, Tzu-yi Chia, Lu Sun, Robert Prins, Benjamin Izar, Deiter Henrik Heiland, Peng Zhang, Adam Sonabend, Jason Miska, Maciej Lesniak, Junfei Zhao, Catalina Lee-Chang
Immunotherapy has revolutionized cancer treatment but has yet to be translated into brain tumors. Studies in other solid tumors suggest a central role of B-cell immunity in driving immune-checkpoint-blockade efficacy. Using single-cell and single-nuc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45e32cb92415093d868bed4ef4d99df7
https://doi.org/10.21203/rs.3.rs-2399170/v1
https://doi.org/10.21203/rs.3.rs-2399170/v1
Autor:
David Hou, Brandyn Castro, Andrew Zolp, Mark Dapash, Victor Arrieta, Jana Biermann, Johannes Melms, Maciej Lesniak, Benjamin Izar, Jason Miska, Junfei Zhao, Catalina Lee-Chang
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Andrew Zolp
Publikováno v:
JAAPA : official journal of the American Academy of Physician Assistants. 35(11)
Autor:
Brandyn Castro, Mariafausta Fischietti, Andrew Zolp, Junfei Zhao, David Hou, Linh Nguyen, Hanxiao Wan, Peng Zhang, Yu Han, Aurora Lopez-Rosas, Leonidas Platanias, Roger Stupp, Jason Miska, Maciej Lesniak, Catalina Lee-Chang
Publikováno v:
Neuro-Oncology. 24:vii220-vii221
Glioblastoma (GBM) continues to retain its dismal prognosis despite numerous new therapeutic modalities to target various aspects of the tumor. There is a need to identify new, and even personalized, targetable GBM specific antigens. Our B-cell-based
Publikováno v:
Neuro-Oncology. 24:vii6-vii7
Glioblastoma (GBM) is the most prevalent and lethally recurrent central nervous system neoplasm, but its therapeutic advancement has stagnated for over 15 years. One major hurdle in front of clinical breakthroughs has been the relative lack of real-t
Autor:
Andrew Zolp
Publikováno v:
JAAPA : official journal of the American Academy of Physician Assistants. 35(5)
Calcitonin gene-related peptide antagonists are a novel new class of medications that have been shown to reduce migraine headache pain and bothersome symptoms in patients who have had an insufficient response to triptans or for whom triptans are cont
Autor:
Aida Rashidi, Andrew Zolp, Leah K. Billingham, Tzu-yi Chia, Steven M. Markwell, Crismita Dmello, Victor A. Arrieta, Irene M. Jacob, Aurora Lopez-Rosas, Peng Zhang, David Hou, Brandyn Castro, Joshua L. Katz, Junfei Zhao, Atique U. Ahmed, Daniel J. Brat, Dieter H. Heiland, Catalina Lee Chang, Maciej S. Lesniak, Navdeep Chandel, Jason Miska
Publikováno v:
SSRN Electronic Journal.
Autor:
Eunus S. Ali, Shreya Budhiraja, Charles David James, Ella Perrault, Anindita Basu, Luke Tomes, Sebastian Pott, Issam Ben-Sahra, Atique Ahmed, Andrew Zolp, Shivani Baisiwala, Peiyu Lin, Isabelle Preddy, Jack Shireman, Cheol Park
Glioblastoma (GBM) remains one of the most resistant and fatal forms of cancer. Previous studies have examined primary and recurrent GBM tumors, but it is difficult to study tumor evolution during therapy where resistance develops. To investigate thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8165007756b8f62ca40b6d1b8f2eb995
https://doi.org/10.1101/2021.11.23.469785
https://doi.org/10.1101/2021.11.23.469785
Autor:
Adam M. Sonabend, Li Chen, Shivani Baisiwala, Andrew Zolp, Khizar Nandoliya, Ella Perrault, Shreya Budhiraja, Cheol Park, Atique Ahmed, Crismita Dmello, Gabriel Dara
Publikováno v:
Neuro Oncol
Glioblastoma (GBM) is the most aggressive and common type of adult malignant brain tumor, with a median survival of only 21 months. To identify which genes drive its highly aggressive phenotype, we performed a genome-wide CRISPR-Cas9 knockout screen.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f49de047a721f727a1c9143b7be6cb
https://europepmc.org/articles/PMC8598895/
https://europepmc.org/articles/PMC8598895/